Akcea Therapeutics, Inc. Net Income
Akcea Therapeutics, Inc. reported Net Income of -$49.58 million for the 3-month period ending 2020-06-30, per its 10-Q filed 2020-08-05.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLoss · last filed 2020-08-05
- Akcea Therapeutics, Inc. net income (loss) attributable to parent for the quarter ending 2020-06-30 was -$49.58M.
- Akcea Therapeutics, Inc. net income (loss) attributable to parent for the quarter ending 2020-03-31 was -$42.85M, a 257.61% decline year-over-year.
- Akcea Therapeutics, Inc. net income (loss) attributable to parent for the quarter ending 2019-12-31 was $82.41M.
- Akcea Therapeutics, Inc. net income (loss) attributable to parent for the quarter ending 2019-09-30 was -$31.50M.
- Akcea Therapeutics, Inc. net income (loss) attributable to parent for fiscal 2019 was $40.77M.
- Akcea Therapeutics, Inc. net income (loss) attributable to parent for fiscal 2018 was -$225.82M.
- Akcea Therapeutics, Inc. net income (loss) attributable to parent for fiscal 2017 was -$121.56M.
- Akcea Therapeutics, Inc. net income (loss) attributable to parent for fiscal 2016 was -$83.22M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 3 month as first filed | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 6 month as first filed | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 9 month as first filed | Net Income (Loss) Attributable to Parent 12 month | Net Income (Loss) Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2020-06-30 | -$49.58M 10-Q · filed 2020-08-05 | -$92.43M 10-Q · filed 2020-08-05 | -$10.02M derived: sum of 3 quarters · filed 2020-08-05 | -$41.52M derived: sum of 4 quarters · filed 2020-08-05 | ||||
| 2020-03-31 | -$42.85M 10-Q · filed 2020-05-06 | $39.56M derived: sum of 2 quarters · filed 2020-05-06 | $8.06M derived: sum of 3 quarters · filed 2020-05-06 | -$29.27M derived: sum of 4 quarters · filed 2020-08-05 | ||||
| 2019-12-31 | $82.41M 10-K · filed 2020-03-02 | $50.91M derived: sum of 2 quarters · filed 2020-03-02 | $13.59M derived: sum of 3 quarters · filed 2020-08-05 | $40.77M 10-K · filed 2020-03-02 | ||||
| 2019-09-30 | -$31.50M 10-K · filed 2020-03-02 | -$68.82M derived: sum of 2 quarters · filed 2020-08-05 | -$41.63M 10-Q · filed 2019-11-06 | -$112.19M derived: sum of 4 quarters · filed 2020-08-05 | ||||
| 2019-06-30 | -$37.32M 10-Q · filed 2020-08-05 | -$10.14M 10-Q · filed 2020-08-05 | -$80.69M derived: sum of 3 quarters · filed 2020-08-05 | -$144.28M derived: sum of 4 quarters · filed 2020-08-05 | ||||
| 2019-03-31 | $27.19M 10-Q · filed 2020-05-06 | -$43.37M derived: sum of 2 quarters · filed 2020-05-06 | -$106.96M derived: sum of 3 quarters · filed 2020-05-06 | -$169.01M derived: sum of 4 quarters · filed 2020-05-06 | ||||
| 2018-12-31 | -$70.56M 10-K · filed 2020-03-02 | -$134.15M derived: sum of 2 quarters · filed 2020-03-02 | -$196.19M derived: sum of 3 quarters · filed 2020-03-02 | -$225.82M 10-K · filed 2020-03-02 | ||||
| 2018-09-30 | -$63.59M 10-K · filed 2020-03-02 | -$125.64M derived: sum of 2 quarters · filed 2020-03-02 | -$155.26M 10-Q · filed 2019-11-06 | -$174.97M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2018-06-30 | -$62.05M 10-K · filed 2020-03-02 | -$91.67M 10-Q · filed 2019-08-07 | -$111.38M derived: sum of 3 quarters · filed 2020-03-02 | -$129.02M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2018-03-31 | -$29.63M 10-K · filed 2020-03-02 | -$49.33M derived: sum of 2 quarters · filed 2020-03-02 | -$66.97M derived: sum of 3 quarters · filed 2020-03-02 | -$87.33M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2017-12-31 | -$19.71M 10-K · filed 2019-03-01 | -$23.36M 10-K · filed 2018-02-28 | -$37.34M derived: sum of 2 quarters · filed 2019-03-01 | -$57.70M derived: sum of 3 quarters · filed 2019-03-01 | -$121.56M 10-K · filed 2020-03-02 | -$109.75M 10-K · filed 2018-02-28 | ||
| 2017-09-30 | -$17.64M 10-K · filed 2019-03-01 | -$14.09M 10-Q · filed 2017-11-07 | -$38.00M derived: sum of 2 quarters · filed 2019-03-01 | -$101.85M 10-Q · filed 2018-11-06 | -$86.39M 10-Q · filed 2017-11-07 | -$135.68M derived: sum of 4 quarters · filed 2019-03-01 | ||
| 2017-06-30 | -$20.36M 10-K · filed 2019-03-01 | -$11.94M 10-Q · filed 2017-08-09 | -$84.21M 10-Q · filed 2018-08-07 | -$72.30M 10-Q · filed 2017-08-09 | -$118.05M derived: sum of 3 quarters · filed 2019-03-01 | -$137.85M derived: sum of 4 quarters · filed 2019-03-01 | ||
| 2017-03-31 | -$63.86M 10-K · filed 2019-03-01 | -$60.35M 10-K · filed 2018-02-28 | -$97.69M derived: sum of 2 quarters · filed 2019-03-01 | -$117.50M derived: sum of 3 quarters · filed 2019-03-01 | -$131.11M derived: sum of 4 quarters · filed 2019-03-01 | |||
| 2016-12-31 | -$33.83M 8-K · filed 2018-09-18 | -$53.64M derived: sum of 2 quarters · filed 2018-09-18 | -$67.25M derived: sum of 3 quarters · filed 2018-09-18 | -$83.22M 10-K · filed 2019-03-01 | ||||
| 2016-09-30 | -$19.81M 8-K · filed 2018-09-18 | -$33.42M derived: sum of 2 quarters · filed 2018-09-18 | -$49.38M 10-Q · filed 2017-11-07 | |||||
| 2016-06-30 | -$13.62M 8-K · filed 2018-09-18 | -$29.57M 10-Q · filed 2017-08-09 | ||||||
| 2016-03-31 | -$15.96M 8-K · filed 2018-09-18 | |||||||
| 2015-12-31 | -$61.42M 8-K · filed 2018-09-18 |